156 related articles for article (PubMed ID: 33213115)
1. Downregulation of plasma microRNA-29c-3p expression may be a new risk factor for diabetic retinopathy.
Torus B; Korkmaz H; Ozturk KH; Şirin FB; Argun M; Şevik S; Tök L
Minerva Endocrinol (Torino); 2023 Mar; 48(1):42-50. PubMed ID: 33213115
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic role of serum miR-20b, miR-17-3p, HOTAIR, and MALAT1 in diabetic retinopathy.
Shaker OG; Abdelaleem OO; Mahmoud RH; Abdelghaffar NK; Ahmed TI; Said OM; Zaki OM
IUBMB Life; 2019 Mar; 71(3):310-320. PubMed ID: 30468285
[TBL] [Abstract][Full Text] [Related]
3. Highly-Expressed MiR-221-3p Distinctly Increases the Incidence of Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus.
Zhao L; Pan Q
Transl Vis Sci Technol; 2023 Oct; 12(10):17. PubMed ID: 37856104
[TBL] [Abstract][Full Text] [Related]
4. Circulating miR-29c-3p is downregulated in patients with acromegaly.
Korkmaz H; Hekimler Öztürk K; Torus B
Turk J Med Sci; 2021 Aug; 51(4):2081-2086. PubMed ID: 34013701
[TBL] [Abstract][Full Text] [Related]
5. microRNA Expression Profile in the Vitreous of Proliferative Diabetic Retinopathy Patients and Differences from Patients Treated with Anti-VEGF Therapy.
Friedrich J; Steel DHW; Schlingemann RO; Koss MJ; Hammes HP; Krenning G; Klaassen I
Transl Vis Sci Technol; 2020 May; 9(6):16. PubMed ID: 32821513
[TBL] [Abstract][Full Text] [Related]
6. Serum miR-122 levels correlate with diabetic retinopathy.
Pastukh N; Meerson A; Kalish D; Jabaly H; Blum A
Clin Exp Med; 2019 May; 19(2):255-260. PubMed ID: 30673918
[TBL] [Abstract][Full Text] [Related]
7. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
8. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.
Gong Q; Li F; Xie J; Su G
Endocrine; 2019 Jul; 65(1):35-45. PubMed ID: 30980286
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy.
Yang Y; Liu Y; Li Y; Chen Z; Xiong Y; Zhou T; Tao W; Xu F; Yang H; Ylä-Herttuala S; Chaurasia SS; Adam WC; Yang K
J Clin Endocrinol Metab; 2020 Nov; 105(11):3404-15. PubMed ID: 32797181
[TBL] [Abstract][Full Text] [Related]
10. Plasma
Jiang Q; Lyu XM; Yuan Y; Wang L
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
[TBL] [Abstract][Full Text] [Related]
11. [The effect of anti-VEGF therapy on the expression levels of TGF-β and related microRNAs in the vitreous of patients with proliferative diabetic retinopathy].
Guo J; Liu ZH; Pan M; An GQ; Du LP; Zhou PY; Jin XM
Zhonghua Yan Ke Za Zhi; 2021 Dec; 57(12):922-929. PubMed ID: 34865451
[No Abstract] [Full Text] [Related]
12. MicroRNA-425-5p Is Involved in the Development of Diabetic Retinopathy and Regulates the Proliferation and Migration of Retinal Microvascular Endothelial Cells.
Liu X; Zhou Y; Liu Y; Wang Q; Pan L
Ophthalmic Res; 2022; 65(1):60-67. PubMed ID: 34571504
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of miR-374a is involved in the progression of diabetic retinopathy and regulates the proliferation and migration of retinal microvascular endothelial cells.
Wang Z; Zhang X; Wang Y; Xiao D
Clin Exp Optom; 2022 Apr; 105(3):287-292. PubMed ID: 33941051
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
15. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
16. Mi-RNA-93 and Mi-RNA-152 in the Diagnosis of Type 2 Diabetes and Diabetic Retinopathy.
Saleh AA; El-Hefnawy SM; Kasemy ZA; Alhagaa AA; Nooh MZ; Arafat ES
Br J Biomed Sci; 2022; 79():10192. PubMed ID: 35996507
[No Abstract] [Full Text] [Related]
17. Plasma Levels and Diagnostic Significance of miR-335-3p and EGFR in Diabetic Retinopathy.
Xia Z; Yang X; Zheng Y; Yi G; Wu S
Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443588
[TBL] [Abstract][Full Text] [Related]
18. Relationship between elevated microRNAs and growth factors levels in the vitreous of patients with proliferative diabetic retinopathy.
Guo J; Zhou P; Pan M; Liu Z; An G; Han J; Dai F; Du L; Jin X
J Diabetes Complications; 2021 Nov; 35(11):108021. PubMed ID: 34420810
[TBL] [Abstract][Full Text] [Related]
19. Unique molecular signatures of microRNAs in ocular fluids and plasma in diabetic retinopathy.
Smit-McBride Z; Nguyen AT; Yu AK; Modjtahedi SP; Hunter AA; Rashid S; Moisseiev E; Morse LS
PLoS One; 2020; 15(7):e0235541. PubMed ID: 32692745
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs (-146a, -21 and -34a) are diagnostic and prognostic biomarkers for diabetic retinopathy.
Helal HG; Rashed MH; Abdullah OA; Salem TI; Daifalla A
Biomed J; 2021 Dec; 44(6 Suppl 2):S242-S251. PubMed ID: 35304162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
